Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

ParkDB: a Parkinson's disease gene expression database.

Taccioli C, Tegnér J, Maselli V, Gomez-Cabrero D, Altobelli G, Emmett W, Lescai F, Gustincich S, Stupka E.

Database (Oxford). 2011 May 18;2011:bar007. doi: 10.1093/database/bar007. Print 2011.

2.

Parkinson's disease: mechanisms and models.

Dauer W, Przedborski S.

Neuron. 2003 Sep 11;39(6):889-909. Review.

3.

PDbase: a database of Parkinson's disease-related genes and genetic variation using substantia nigra ESTs.

Yang JO, Kim WY, Jeong SY, Oh JH, Jho S, Bhak J, Kim NS.

BMC Genomics. 2009 Dec 3;10 Suppl 3:S32. doi: 10.1186/1471-2164-10-S3-S32.

4.

Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death.

Bossers K, Meerhoff G, Balesar R, van Dongen JW, Kruse CG, Swaab DF, Verhaagen J.

Brain Pathol. 2009 Jan;19(1):91-107. doi: 10.1111/j.1750-3639.2008.00171.x. Epub 2008 May 7.

PMID:
18462474
5.

PDON: Parkinson's disease ontology for representation and modeling of the Parkinson's disease knowledge domain.

Younesi E, Malhotra A, Gündel M, Scordis P, Kodamullil AT, Page M, Müller B, Springstubbe S, Wüllner U, Scheller D, Hofmann-Apitius M.

Theor Biol Med Model. 2015 Sep 22;12:20. doi: 10.1186/s12976-015-0017-y.

6.

Using the Gene Ontology to Annotate Key Players in Parkinson's Disease.

Foulger RE, Denny P, Hardy J, Martin MJ, Sawford T, Lovering RC.

Neuroinformatics. 2016 Jul;14(3):297-304. doi: 10.1007/s12021-015-9293-2.

8.

Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.

During MJ, Kaplitt MG, Stern MB, Eidelberg D.

Hum Gene Ther. 2001 Aug 10;12(12):1589-91.

PMID:
11529246
9.

Gene expression profiling in progressively MPTP-lesioned macaques reveals molecular pathways associated with sporadic Parkinson's disease.

Ohnuki T, Nakamura A, Okuyama S, Nakamura S.

Brain Res. 2010 Jul 30;1346:26-42. doi: 10.1016/j.brainres.2010.05.066. Epub 2010 Jun 1.

PMID:
20513370
10.

Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease.

Gründemann J, Schlaudraff F, Haeckel O, Liss B.

Nucleic Acids Res. 2008 Apr;36(7):e38. doi: 10.1093/nar/gkn084. Epub 2008 Mar 10.

11.

Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease.

Miller RM, Kiser GL, Kaysser-Kranich TM, Lockner RJ, Palaniappan C, Federoff HJ.

Neurobiol Dis. 2006 Feb;21(2):305-13. Epub 2005 Sep 6.

PMID:
16143538
12.

A susceptibility locus for Parkinson's disease maps to chromosome 2p13.

Gasser T, Müller-Myhsok B, Wszolek ZK, Oehlmann R, Calne DB, Bonifati V, Bereznai B, Fabrizio E, Vieregge P, Horstmann RD.

Nat Genet. 1998 Mar;18(3):262-5.

PMID:
9500549
13.

Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson's disease pathogenesis.

Licker V, Turck N, Kövari E, Burkhardt K, Côte M, Surini-Demiri M, Lobrinus JA, Sanchez JC, Burkhard PR.

Proteomics. 2014 Mar;14(6):784-94. doi: 10.1002/pmic.201300342. Epub 2014 Feb 18.

PMID:
24449343
14.

Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.

Perier C, Bender A, García-Arumí E, Melià MJ, Bové J, Laub C, Klopstock T, Elstner M, Mounsey RB, Teismann P, Prolla T, Andreu AL, Vila M.

Brain. 2013 Aug;136(Pt 8):2369-78. doi: 10.1093/brain/awt196.

PMID:
23884809
15.

Systematic analysis of microarray datasets to identify Parkinson's disease‑associated pathways and genes.

Feng Y, Wang X.

Mol Med Rep. 2017 Mar;15(3):1252-1262. doi: 10.3892/mmr.2017.6124. Epub 2017 Jan 16.

16.
17.

Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms.

Prediger RD.

J Alzheimers Dis. 2010;20 Suppl 1:S205-20. doi: 10.3233/JAD-2010-091459. Review.

PMID:
20182024
18.

Authentically phosphorylated α-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson's disease.

Sato H, Arawaka S, Hara S, Fukushima S, Koga K, Koyama S, Kato T.

J Neurosci. 2011 Nov 16;31(46):16884-94. doi: 10.1523/JNEUROSCI.3967-11.2011.

19.

Gene and protein signatures in sporadic Parkinson's disease and a novel genetic model of PD.

Mandel SA, Fishman T, Youdim MB.

Parkinsonism Relat Disord. 2007;13 Suppl 3:S242-7. doi: 10.1016/S1353-8020(08)70009-9. Review.

PMID:
18267243
20.

Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes.

Berkowitz LA, Hamamichi S, Knight AL, Harrington AJ, Caldwell GA, Caldwell KA.

J Vis Exp. 2008 Jul 18;(17). pii: 835. doi: 10.3791/835.

Supplemental Content

Support Center